远大医药盘中涨超8% 多款新药研发迎突破

DoNews
May 20

5月20日,远大医药(00512)盘中涨幅一度超过8%,现报8.86港元。公司近期在新药研发方面取得多项进展。其脓毒症治疗FIC新药STC3141临床II期研究成功,有望成为重症治疗领域突破性疗法。同时,创新RDC产品TLX591加入国际多中心III期临床试验的申请获国家药监局受理,TLX591-CDx中国III期临床研究已完成全部患者给药,并计划年内递交新药上市申请。多重利好推动股价上涨。免责...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10